On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- The colonoscopy reimbursement math is not adding up (Becker’s Healthcare)
- Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey (Fierce Healthcare)
- Microbiome Testing Needs Its Standards Moment (Op-Med)
- Combined GI Endoscopy Has a Quality Assurance Gap. At Current Volume, That Gap Has Institutional Consequences. (HIT Consultant)
- Computer-aided polyp detection multicenter international randomized controlled study with a focus on community clinics: Gastroenterology Artificial INtelligence system for detecting colorectal polyps (ScienceDirect)
- Researchers Analyzing Colon Cancer Screenings Find Hope for Higher Retest Rates (Rutgers)
- Exclusive: Co-Founded By Former Whoop CTO, Throne Science Raises $10M To Track Gut Health From The Toilet (Crunchbase)
- GI Societies Oppose Proposed Federal Rule That Would Reshape Biomedical Research (American College of Gastroenterology)
